Teva launches generic Lipitor sales in Canada
Sales of Pfizer's Lipitor in Canada total C$1.3 billion a year.
Teva will begin shipments immediately.
Branded Lipitor is made by Pfizer Inc. (NYSE: PFE; LSE: PFZ). Brand sales in Canada total C$1.3 billion a year.
Teva's share price rose 0.3% on Nasdaq yesterday to $55.38, but fell 2% at the opening on the TASE today to NIS 212.60, in line with the general market slide.
Published by Globes [online], Israel business news - www.globes-online.com - on May 20, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010
- Tel Aviv market report
- Tel Aviv Stock Exchange
- Israeli stocks in NY
- Arbitrage gaps for dual-listed stocks
- Israeli stocks in Europe
- Israeli stocks on other markets
- Tel Aviv 25 options
- Mutual funds
- Current representative shekel rates
- Historical representative shekel rates
- Bank shekel rates
- Shekel/dollar options